Merck’s New Covid-19 Pill: Molnupiravir, Explained
The Wall Street Journal The Wall Street Journal
5.18M subscribers
14,808 views
0

 Published On Oct 13, 2021

After almost two years, there’s a new, easy-to-take Covid-19 pill treatment. Merck’s molnupiravir drug could be available as soon as the end of the year if it gets authorized by the FDA. It would help make Covid-19 a more manageable disease, marking a pivotal turning point in the pandemic.

#Molnupiravir #CovidPill #DanielaHernandez

show more

Share/Embed